Kakehashi

Enterprise Systems (Healthcare) · Tokyo, Japan · Founded 2016 · Privately Held (backing)

Developer of a pharmacy experience platform designed to support patient satisfaction and work style reforms in pharmacies. Kakehashi is based in Tokyo, Japan and was founded in 2016. It was valued at $296 million at its later-stage round in Mar 2023, the last priced event on record. It has raised $219 million across 1 recorded round; the latest was a $70.3 million Series C in Mar 2023.

PMV mark · valuation
$295.6M
Oct 2026
Priced at
its later-stage round
Mar 2023
Total raised
$219.1M
Last round
Later Stage VC (Series C)
Mar 2023

Who backs Kakehashi?

27 investors
InvestorType
Mitsubishi UFJ CapitalOther
Salesforce VenturesVenture capital
SMBC Venture CapitalVenture capital
J-StartupOther
DNX VenturesVenture capital
Sony Innovation FundVenture capital
JIC Venture Growth InvestmentsVenture capital
Globis Capital PartnersVenture capital
Aozora Corporate InvestmentOther
Coral CapitalVenture capital
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kakehashi investors

27 investors are on record for Kakehashi, including Mitsubishi UFJ Capital, Salesforce Ventures, SMBC Venture Capital and J-Startup. By type, the record holds 10 venture capital firms and 2 private equity firms. The Series C in Mar 2023 drew 8 investors.

Free account
More of Kakehashi with a free account
  • ·The complete investor list: 27 names
  • ·Watch Kakehashi: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Kakehashi in enterprise systems (healthcare). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View